Iambic Therapeutics Inc.

Iambic Therapeutics Inc.

IAM

NASDAQTechnologySoftware - Application

最新資料

US$23.31

+US$4.40 · +23.27%

載入中

IAM公司概覽

公司概況

Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.